Mounjaro Price Surge Sparks Panic Among UK Weight Loss Patients
Health 5 days ago
The cost of Mounjaro, a popular weight loss drug, will more than double in the UK from September 1, sparking panic among private users. Manufacturer Eli Lilly claims the hike aligns with global pricing, though NHS patients remain unaffected due to pre-negotiated rates. Over 1.5 million Britons rely on weight loss medications, with 90% paying out-of-pocket for treatments like Mounjaro.
Social media erupted with outrage as patients shared fears of regaining weight without affordable access. Experts warn only 2-10% maintain weight loss after stopping GLP-1 drugs like Mounjaro. While NHS prescriptions require strict BMI and comorbidity criteria, private clinics offer more flexible eligibility at higher costs.
Pharmacists suggest switching to cheaper alternatives like Wegovy, though transition requires medical supervision. GPs emphasize the need for careful monitoring during medication changes to manage side effects and sustain weight loss progress amid the pricing crisis.